--- the subscriber area has no ads and those above are not selected or endorsed by this site ---

Akoustis 3Q22 schedule and trade notes ?3

06:53 26-Apr-22

To the other minor news here, I will add that BGC's Capitalab has added multi-metric enhancements to its Rates Optimisation which allow the service to consider Risk Weighted Asset capital together with Initial Margin.  That does make the service substantially more useful, but I doubt it will have much immediate impact on BGCP.

Akoustis has scheduled its fiscal third quarter report for the morning of Monday, May 2nd.  The average of 4 analysts estimates is for a loss of 22 cents per share from $4.7M of revenue, increasing to $6.2M this quarter.  Monday morning reports aren't the way to get a lot of attention.  So, I'm not expecting a lot from this one.  Labor and supply chain shortages are both to be expected; government help in the near term is not.  That may have lead to increased shorting recently, and I will be looking for the early April figures tomorrow evening.  Fundamentally, Akoustis only has to show manufacturing and maybe sales progress for this report, as far as I am concerned, and the price is definitely right below $5.  The Fed's jawboning has got index decline into full gear now, as predicted.  This affects all prices in the short term, but won't affect the M&A that I anticipate. 

I see quality high yield bonds and preferred shares as the best refuge; the next, and probably penultimate, ex-date for GMLPF is May 6th.   The annualized return the 21.80 last traded price would be 29%, assuming the shares are called at the end of October, and if a broker allows you to buy it.  LUMN and/or CTBB remain more accessible alternatives depending on the time horizon and level of safety desired.  VIRT is another option, with the share price down close to $34 despite the negative index correlation and supportive market volume.

In the meantime, we're seeing further evidence of populist division in the French election.  My outlook on bargain natural gas names is unaffected, even as hydrocarbon prices get knocked back down on expectations for stalemate or conclusion in Ukraine.  Western political incumbents trying to hold the line makes me shade even further toward the former, at taxpayer expense.  The cracks are also showing in developing markets like India, which is keeping me hands off EBIX despite sub $30 pricing and propaganda.  Buckle up, everyone.

Topics:

• none